Compare AbCellera Biologics Inc (ABCL) vs Asana Inc. (ASAN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Asana Inc. — how do they compare? AbCellera Biologics Inc trades at $7.1 (market cap $2.35B), while Asana Inc. trades at $7.08 (market cap $1.73B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Asana Inc. nearer its low. Which is the better fit depends on your goals.
| ABCL | ASAN | |
|---|---|---|
Market Cap | $2.35B | $1.73B |
Sector | Health | Consumer Cyclical |
52-Week High | $8.12 | $15.35 |
52-Week Low | $2.78 | $5.46 |
Enterprise Value | $1.99B | $1.55B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Asana Inc.
Asana Inc is a software company. The company provides a platform for work management that helps teams orchestrate work, from daily tasks to cross-functional strategic initiatives. It helps plan marketing campaigns, streamlines processes, manages sales, and manage product launches. Also, the company provides project management and workflow management solutions.
Read more on ASAN →
